quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:28:37·55d
ANALYSTRating
GoodRx Holdings Inc. logo

GoodRx downgraded by Analyst

GDRX· GoodRx Holdings Inc.
Technology
Original source

Companies

  • GDRX
    GoodRx Holdings Inc.
    Technology

Recent analyst ratings

  • Feb 27UpdateAnalyst-
  • Jan 22UpdateJefferies$2.75
  • Dec 9UpdateBarclays$3.00
  • Aug 11UpdateRaymond James-
  • Dec 4UpdateMizuho$5.00
  • Aug 9UpdateRaymond James$10.00

Related

  • PR6d
    GoodRx Announces Date for First Quarter 2026 Earnings Release and Conference Call
  • INSIDER8d
    SEC Form 4 filed by Mcginnis Christopher A
  • INSIDER8d
    SEC Form 4 filed by Barnes Wendy Lynn
  • PR8d
    GoodRx Now Offers Access to Wegovy® HD at $399 Per Month Self-Pay Price
  • PR14d
    GoodRx Expands Access to Eli Lilly and Company's New Oral GLP-1, Foundayo™, and Zepbound® KwikPen® with Self-Pay Pricing at More Than 70,000 Pharmacies Nationwide
  • SEC20d
    GoodRx Holdings Inc. filed SEC Form 8-K: Leadership Update
  • SEC27d
    GoodRx Holdings Inc. filed SEC Form 8-K: Leadership Update
  • SEC27d
    Amendment: SEC Form SCHEDULE 13G/A filed by GoodRx Holdings Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022